ArticleBriefings in bioinformatics2025
M3Site: multiclass multimodal learning for protein active site identification and classification.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Accurately identifying and classifying protein active sites is crucial for understanding protein mechanisms, drug design, and synthetic biology. Current methods often rely on binary classification and single-modal data, limiting their scope. To address these limitations, we propose M$^{3}$Site, a multimodal framework that integrates protein sequence embeddings, structural graph representations, and functional text annotations for residue-level, multiclass active site prediction. Built upon a curated dataset of 25 883 proteins sourced from UniProt and AlphaFold2, M$^{3}$Site leverages pretrained protein language models, equivariant graph neural networks, and biomedical language models for feature extraction. The function informed cross-attention module enables cross-modal feature fusion, while the adaptive weighted fusion mechanism balances modality contributions. A compound loss function tackles class imbalance, ensuring robust performance. Experimental results show M$^{3}$Site significantly outperforms existing models, and an interactive application has been developed to enhance its practical utility for predictions and visualizations. The dataset, source code for experiments, and interactive application are publicly available at https://github.com/Gift-OYS/M3Site.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.